ResMed Logo

COPD

COPD (chronic obstructive pulmonary disease) is a serious progressive lung disease affecting about 15–25% of adults over 40.1

The world health organisation (WHO) suggests that up to 65 million people worldwide are currently living with moderate to severe COPD.2

To help ease this burden, ResMed helps you provide individualised treatment for your patients with COPD … helping them breathe easier, and work towards a more promising picture with every breath.

COPD treatment options and outcomes

Although there is currently no cure for COPD, treatments are available to help patients with their day-to-day relief and long-term disease management.

What is COPD?

Overview of COPD including signs and symptoms, causes, stages, treatment, economics and patient outcomes. A global problem with economic consequences.

ResMed’s intelligent non-invasive ventilation solution for COPD

ResMed offers you intelligent non-invasive ventilation solutions that can help you tailor treatment to the unique and changing needs of your patients. From ventilators and masks to oxygen options and accessories, ResMed’s solutions work together to help patients breathe easier as they manage their condition.

Role of non-invasive ventilation in COPD

Like all forms of mechanical ventilation, non-invasive ventilation supports a patient’s breathing.

More COPD

Non-Invasive Ventilation (NIV)
Noninvasive ventilation (NIV) provides ventilatory support to patients who suffer from respiratory insufficiency.
Invasive ventilation (IV)
Invasive ventilation (IV) following endotracheal intubation provides ventilatory support for your patients. Learn how IV can become a lifesaving intervention for your patients with respiratory failure.
Getting the most out of ventilation therapy
Comfortable equipment, proper replacement, follow-up and education are critical to helping patients adapt to and stay on therapy.

References

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). “Global Strategy for the Diagnosis, Management and Prevention of COPD, 2010.” (accessed November 9, 2015) Gold Report